|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Merabishvili VM, Petrova NG, Atroshchenko
AV and Kharitonov MV: Epidemiology of prostate cancer (cohort
study). Vopr Onkol. 60:457–463. 2014.(In Russian). PubMed/NCBI
|
|
3
|
Toomey A and Friedman L: Mortality in
cancer patients after a fall-related injury: The impact of cancer
spread and type. Injury. 45:1710–1716. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cho JY, Shim EJ, Kim IS, Nam EM, Choi MY,
Lee KE, Mun YC, Seoung CM, Lee SN, Song DE and Han WS: Cancer of
unknown primary finally revealed to be a metastatic prostate
cancer: A case report. Cancer Res Treat. 41:45–49. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tu SM, Millikan RE, Mengistu B, Delpassand
ES, Amato RJ, Pagliaro LC, Daliani D, Papandreou CN, Smith TL, Kim
J, et al: Bone-targeted therapy for advanced androgen-independent
carcinoma of the prostate: A randomised phase II trial. Lancet.
357:336–341. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suzman DL, Boikos SA and Carducci MA:
Bone-targeting agents in prostate cancer. Cancer Metastasis Rev.
33:619–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Massraf AB and Wand JS: Haemorrhagic
secondary prostatic metastasis of the terminal phalanx of the
thumb. Injury. 29:243–245. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Patel P, Patel J and Siddiqui S:
Recurrence of prostate cancer with cutaneous metastasis after
radical prostatectomy. Case Rep Urol. 2015:8251752015.PubMed/NCBI
|
|
9
|
Ogunmola AO, Shittu OB and Olapade-Olaopa
EO: Cutaneous metastasis from prostate cancer in a nigerian: A case
report and literature review. Afr J Med Med Sci. 42:283–286.
2013.PubMed/NCBI
|
|
10
|
Brown GT, Patel V and Lee CC: Cutaneous
metastasis of prostate cancer: A case report and review of the
literature with bioinformatics analysis of multiple healthcare
delivery networks. J Cutan Pathol. 41:524–528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Keen MA and Hassan I: Cutaneous metastasis
of an advanced prostate cancer. Indian J Dermatol Venereol Leprol.
79:828–829. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martin V, Cuenca X, Lopez S, Albertini AF,
Lang P, Simon JM, Hémery CG, Feuvret L and Mazeron JJ: Iris
metastasis from prostate carcinoma: A case report and review of the
literature. Cancer Radiother. 19:331–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Soe AM, Bordia S, Xiao PQ, Lopez-Morra H,
Tejada J, Atluri S and Krishnaiah M: A rare presentation of
metastasis of prostate adenocarcinoma to the stomach and rectum. J
Gastric Cancer. 14:271–274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hélissey C, Rouanne M, Arnaud FX and Le
Moulec S: Parotid gland metastasis from prostate cancer: Is
docetaxel still the best treatment option? Anticancer Drugs.
26:367–370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang T, Wang Q, Min J, Yu D, Xie D, Wang
Y, Ding D, Chen L, Zou C, Zhang Z and Wang D: Metastasis to the
proximal ureter from prostatic adenocarcinoma: A rare metastatic
pattern. Can Urol Assoc J. 8:E859–E861. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaswala DH, Patel N, Jadallah S and Wang
W: Metastatic prostate cancer to the duodenum: A rare case. J
Family Med Prim Care. 3:166–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Z, Xu S, Zhong C, Gao Y, Liu Q, Zheng
Y, Guo Y, Wang Y, Luo Q and Jiang J: Intramedullary conus
medullaris metastasis from prostate carcinoma: A case report and
review of the literature. Oncol Lett. 7:717–720. 2014.PubMed/NCBI
|
|
18
|
Oliveira JA, Said Rde A, Cartaxo Rde S,
Santos JA and Gondim RL: Laryngeal metastasis of a prostate
carcinoma: One rare entity. Braz J Otorhinolaryngol. 78:1352012.(In
Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Freudlsperger C, Kurth R, Werner MK,
Hoffmann J and Reinert S: Condylar metastasis from prostatic
carcinoma mimicking temporomandibular disorder: A case report. Oral
Maxillofac Surg. 16:79–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bhavsar T, McCue P and Birbe R: Molecular
diagnosis of prostate cancer: Are we up to age? Semin Oncol.
40:259–275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garde SV, Sheth AR, Venkatesan VM, Panchal
CJ, Porter AT and Grignon DJ: Prostate inhibin peptide (PIP) in
prostate cancer: A comparative immunohistochemical study with
prostate-specific antigen (PSA) and prostatic acid phosphatase
(PAP). Cancer Lett. 78:11–17. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bernacki KD, Fields KL and Roh MH: The
utility of PSMA and PSA immunohistochemistry in the cytologic
diagnosis of metastatic prostate carcinoma. Diagn Cytopathol.
42:570–575. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wilson BA, Wang H, Nacev BA, Mease RC, Liu
JO, Pomper MG and Isaacs WB: High-throughput screen identifies
novel inhibitors of cancer biomarker α-methylacyl coenzyme A
racemase (AMACR/P504S). Mol Cancer Ther. 10:825–838. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kumaresan K, Kakkar N, Verma A, Mandal AK,
Singh SK and Joshi K: Diagnostic utility of α-methylacyl CoA
racemase (P504S) & HMWCK in morphologically difficult prostate
cancer. Diagn Pathol. 5:832010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen Y, Wang Z, Zhu J, Chen Y, Gu W and
Liu Q: α-Methylacyl-CoA racemase (P504S) is a useful marker for the
differential diagnosis of solid pseudopapillary neoplasm of the
pancreas. Ann Diagn Pathol. 18:146–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Murray NP, Calaf GM, Badinez L, Dueñas R,
Badinez O, Orellana N, Reyes E and Fuentealba C: P504S expressing
circulating prostate cells as a marker for prostate cancer. Oncol
Rep. 24:687–692. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fichtenbaum EJ, Marsh WL Jr and Zynger DL:
CK5, CK5/6, and double-stains CK7/CK5 and p53/CK5 discriminate in
situ vs. invasive urothelial cancer in the prostate. Am J Clin
Pathol. 138:190–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aggarwal R, Zhang T, Small EJ and
Armstrong AJ: Neuroendocrine prostate cancer: Subtypes, biology,
and clinical outcomes. J Natl Compr Canc Netw. 12:719–726.
2014.PubMed/NCBI
|
